Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT

v3.24.1.1.u2
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Mar. 31, 2021 [1]   56,915      
Beginning balance at Mar. 31, 2021 [1] $ (199,936) $ 570 $ 606,431 $ (806,081) $ (856)
Increase (Decrease) in Stockholders' Equity          
Net income (loss) 38,355     38,355  
Foreign currency translation adjustments, net of income taxes (567)       (567)
Shares issued under employee stock purchase plan (in shares)   389      
Shares issued under employee stock purchase plan 1,762 $ 4 1,758    
Shares issued under employee incentive plans, net (in shares)   2,308      
Shares issued under employee incentive plans, net 0 $ 23 (23)    
Shares issued in connection with business acquisition (in shares)   821      
Shares issued in connection with business acquisition 2,818 $ 8 2,810    
Stock-based compensation $ 13,829   13,829    
Ending balance (in shares) at Mar. 31, 2022 60,433 60,433      
Ending balance at Mar. 31, 2022 $ (143,739) $ 605 624,805 (767,726) (1,423)
Increase (Decrease) in Stockholders' Equity          
Net income (loss) (879)        
Foreign currency translation adjustments, net of income taxes $ (1,276)        
Ending balance (in shares) at Jun. 30, 2022 90,606 90,606      
Ending balance at Jun. 30, 2022 $ (76,500) $ 907 693,896 (768,604) (2,699)
Beginning balance (in shares) at Mar. 31, 2022 60,433 60,433      
Beginning balance at Mar. 31, 2022 $ (143,739) $ 605 624,805 (767,726) (1,423)
Increase (Decrease) in Stockholders' Equity          
Net income (loss) (8,303)        
Foreign currency translation adjustments, net of income taxes (2,574)        
Ending balance (in shares) at Sep. 30, 2022   92,158      
Ending balance at Sep. 30, 2022 $ (82,535) $ 922 696,567 (776,027) (3,997)
Beginning balance (in shares) at Mar. 31, 2022 60,433 60,433      
Beginning balance at Mar. 31, 2022 $ (143,739) $ 605 624,805 (767,726) (1,423)
Increase (Decrease) in Stockholders' Equity          
Net income (loss) (8,190)        
Foreign currency translation adjustments, net of income taxes $ (1,094)        
Ending balance (in shares) at Dec. 31, 2022 93,144 93,144      
Ending balance at Dec. 31, 2022 $ (77,963) $ 932 699,536 (775,914) (2,517)
Beginning balance (in shares) at Mar. 31, 2022 60,433 60,433      
Beginning balance at Mar. 31, 2022 $ (143,739) $ 605 624,805 (767,726) (1,423)
Increase (Decrease) in Stockholders' Equity          
Net income (loss) (18,368)     (18,368)  
Foreign currency translation adjustments, net of income taxes (158)       (158)
Shares issued under employee stock purchase plan (in shares)   600      
Shares issued under employee stock purchase plan 897 $ 6 891    
Shares issued under employee incentive plans, net (in shares)   2,180      
Shares issued under employee incentive plans, net 0 $ 21 (21)    
Shares issued in connection with rights offering, net (in shares)   30,000      
Shares issued in connection with rights offering, net 66,249 $ 300 65,949    
Shares issued in connection with business acquisition (in shares)   361      
Shares issued in connection with business acquisition 0 $ 4 (4)    
Stock-based compensation $ 10,750   10,750    
Ending balance (in shares) at Mar. 31, 2023 93,574 93,574      
Ending balance at Mar. 31, 2023 $ (84,369) $ 936 702,370 (786,094) (1,581)
Beginning balance (in shares) at Jun. 30, 2022 90,606 90,606      
Beginning balance at Jun. 30, 2022 $ (76,500) $ 907 693,896 (768,604) (2,699)
Increase (Decrease) in Stockholders' Equity          
Net income (loss) (7,424)        
Foreign currency translation adjustments, net of income taxes (1,298)        
Ending balance (in shares) at Sep. 30, 2022   92,158      
Ending balance at Sep. 30, 2022 (82,535) $ 922 696,567 (776,027) (3,997)
Increase (Decrease) in Stockholders' Equity          
Net income (loss) 113        
Foreign currency translation adjustments, net of income taxes $ 1,480        
Ending balance (in shares) at Dec. 31, 2022 93,144 93,144      
Ending balance at Dec. 31, 2022 $ (77,963) $ 932 699,536 (775,914) (2,517)
Increase (Decrease) in Stockholders' Equity          
Net income (loss) $ (10,176)        
Ending balance (in shares) at Mar. 31, 2023 93,574 93,574      
Ending balance at Mar. 31, 2023 $ (84,369) $ 936 702,370 (786,094) (1,581)
Increase (Decrease) in Stockholders' Equity          
Net income (loss) (9,142)        
Foreign currency translation adjustments, net of income taxes 249        
Ending balance (in shares) at Jun. 30, 2023   93,705      
Ending balance at Jun. 30, 2023 $ (91,321) $ 938 704,309 (795,236) (1,332)
Beginning balance (in shares) at Mar. 31, 2023 93,574 93,574      
Beginning balance at Mar. 31, 2023 $ (84,369) $ 936 702,370 (786,094) (1,581)
Increase (Decrease) in Stockholders' Equity          
Net income (loss) (12,473)     (12,473)  
Foreign currency translation adjustments, net of income taxes (471)       (471)
Shares issued under employee incentive plans, net (in shares)   1,945      
Shares issued under employee incentive plans, net   $ 20 (20)    
Warrants issued related to long-term debt 49   49    
Stock-based compensation 2,831   2,831    
Ending balance (in shares) at Sep. 30, 2023   95,519      
Ending balance at Sep. 30, 2023 $ (94,433) $ 956 705,230 (798,567) (2,052)
Beginning balance (in shares) at Mar. 31, 2023 93,574 93,574      
Beginning balance at Mar. 31, 2023 $ (84,369) $ 936 702,370 (786,094) (1,581)
Increase (Decrease) in Stockholders' Equity          
Net income (loss) (22,342)     (22,342)  
Foreign currency translation adjustments, net of income taxes 994       994
Shares issued under employee incentive plans, net (in shares)   2,276      
Shares issued under employee incentive plans, net   $ 23 (23)    
Warrants issued related to long-term debt 49   49    
Stock-based compensation $ 3,737   3,737    
Ending balance (in shares) at Dec. 31, 2023 95,850 95,850      
Ending balance at Dec. 31, 2023 $ (101,931) $ 959 706,133 (808,436) (587)
Beginning balance (in shares) at Mar. 31, 2023 93,574 93,574      
Beginning balance at Mar. 31, 2023 $ (84,369) $ 936 702,370 (786,094) (1,581)
Increase (Decrease) in Stockholders' Equity          
Net income (loss) (41,286)     (41,286)  
Foreign currency translation adjustments, net of income taxes (612)       (612)
Shares issued under employee incentive plans, net (in shares)   2,276      
Shares issued under employee incentive plans, net 0 $ 23 (23)    
Warrants issued related to long-term debt 49   49    
Stock-based compensation $ 4,720   4,720    
Ending balance (in shares) at Mar. 31, 2024 95,850 95,850      
Ending balance at Mar. 31, 2024 $ (121,498) $ 959 707,116 (827,380) (2,193)
Beginning balance (in shares) at Jun. 30, 2023   93,705      
Beginning balance at Jun. 30, 2023 (91,321) $ 938 704,309 (795,236) (1,332)
Increase (Decrease) in Stockholders' Equity          
Net income (loss) (3,331)     (3,331)  
Foreign currency translation adjustments, net of income taxes (720)       (720)
Shares issued under employee incentive plans, net (in shares)   1,814      
Shares issued under employee incentive plans, net 0 $ 18 (18)    
Stock-based compensation 939   939    
Ending balance (in shares) at Sep. 30, 2023   95,519      
Ending balance at Sep. 30, 2023 (94,433) $ 956 705,230 (798,567) (2,052)
Increase (Decrease) in Stockholders' Equity          
Net income (loss) (9,869)     (9,869)  
Foreign currency translation adjustments, net of income taxes 1,465       1,465
Shares issued under employee incentive plans, net (in shares)   331      
Shares issued under employee incentive plans, net 0 $ 3 (3)    
Stock-based compensation $ 906   906    
Ending balance (in shares) at Dec. 31, 2023 95,850 95,850      
Ending balance at Dec. 31, 2023 $ (101,931) $ 959 706,133 (808,436) (587)
Increase (Decrease) in Stockholders' Equity          
Net income (loss) $ (18,943)        
Ending balance (in shares) at Mar. 31, 2024 95,850 95,850      
Ending balance at Mar. 31, 2024 $ (121,498) $ 959 $ 707,116 $ (827,380) $ (2,193)
[1] The March 31, 2021 ending total shareholders’ deficit reflects the impact of the restatement totaling $87.7 million related to SSP and warrant classification adjustments prior to that time, including a $67.5 million increase of Accumulated deficit and a $20.2 million decrease of Additional paid-in -capital.